234 related articles for article (PubMed ID: 28830306)
1. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H
Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306
[TBL] [Abstract][Full Text] [Related]
2. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
Pihlstrøm L; Berge V; Rengmark A; Toft M
Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
[TBL] [Abstract][Full Text] [Related]
6. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.
Matsumoto L; Takuma H; Tamaoka A; Kurisaki H; Date H; Tsuji S; Iwata A
PLoS One; 2010 Nov; 5(11):e15522. PubMed ID: 21124796
[TBL] [Abstract][Full Text] [Related]
7. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation in Parkinson's disease.
Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
[TBL] [Abstract][Full Text] [Related]
11. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
Jowaed A; Schmitt I; Kaut O; Wüllner U
J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061
[TBL] [Abstract][Full Text] [Related]
12. [Neurodegeneration and epigenetics].
Iwata A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):269-73. PubMed ID: 23373314
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
[TBL] [Abstract][Full Text] [Related]
14. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
Aguiar Pde C; Lessa PS; Godeiro C; Barsottini O; Felício AC; Borges V; Silva SM; Saba RA; Ferraz HB; Moreira-Filho CA; Andrade LA
Mov Disord; 2008 Jul; 23(9):1228-33. PubMed ID: 18464276
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
[TBL] [Abstract][Full Text] [Related]
16. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
[TBL] [Abstract][Full Text] [Related]
17. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers.
Uslu A; Ergen M; Demirci H; Lohmann E; Hanagasi H; Demiralp T
Clin Neurophysiol; 2020 Jul; 131(7):1444-1452. PubMed ID: 32388155
[TBL] [Abstract][Full Text] [Related]
18. Common variants in PARK loci and related genes and Parkinson's disease.
Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
[TBL] [Abstract][Full Text] [Related]
19. Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients.
Song Y; Ding H; Yang J; Lin Q; Xue J; Zhang Y; Chan P; Cai Y
Neurosci Lett; 2014 May; 569():85-8. PubMed ID: 24721670
[TBL] [Abstract][Full Text] [Related]
20. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
